Skip to main content
Premium Trial:

Request an Annual Quote

Jackson ImmunoResearch Secures Non-Exclusive Rights to Thermo Fisher Fluorescent Dyes

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific announced today that it has entered into a collaboration with Jackson ImmunoResearch Laboratories to facilitate the development of fluorescently labeled secondary antibodies for protein research and other applications.
Under the agreement, Jackson will have non-exclusive, global rights to use Thermo’s DyLight fluorescent dyes, which they plan to use in conjunction with Jackson’s secondary antibody line. The dyes are water-soluble, highly fluorescent, and photostable across a range of pH conditions.
Initially, Jackson plans to offer four of Thermo’s DyLight dyes conjugated to nearly 250 affinity-purified secondary antibodies, streptavidin, anti-biotin, anti-digoxin, anti-FITC, and purified immunoglobulins. The company is currently evaluating other DyLight dyes for potential use in its product line.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.